Bupropion vs Nivolumab

Bupropion vs Nivolumab: Overview

This comparison examines the pharmacological differences between Bupropion and Nivolumab.

Mechanism of Action

Bupropion: Norepinephrine-dopamine reuptake inhibitor (NDRI).

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Bupropion — 21 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Bupropion — C13H18ClNO.

Molecular Weight: Bupropion — 239.7420 g/mol.

Type: Bupropion — Small molecule; Nivolumab — Antibody.